- In an 8k filing posted last night, Sucampo Pharmaceuticals (NASDAQ: SCMP) announced that it would not renew COO James Egan’s employment agreement, which expires on … Continue Reading
Read now- The Jefferies Group downgraded Isis Pharmaceuticals (NASDAQ:ISIS) this morning from a Buy rating to an Underperform, causing shares to follow suit by 10%. Zack’s, meanwhile, … Continue Reading
Read now- Shares of Amarin Corporation (NASDAQ:AMRN) moved higher on Thursday after a webpage suggesting ‘Vascepa’ as the brand name for AMR101 – a prescription fish oil … Continue Reading
Read now- Novartis (NYSE:NVS) provided its Q2 earnings report this morning and although revenue fell slightly from $14.92B last year to $14.3B, net profits mirrored last year’s … Continue Reading
Read now- With most global drug companies missing estimates on currency and international economic woes, Baxter (NYSE: BAX) put up an impressive quarter, beating Wall Street’s top … Continue Reading
Read now- Data presented at the International Spine Intervention Society (ISIS) 20th Annual Scientific Meeting demonstrated that Boston Scientific’s (NYSE: BSX) Infinion™ 16 Percutaneous Lead effectively relieved … Continue Reading
Read now- The world’s largest insulin producer, Novo Nordisk (NYSE:NVO), announced a major setback this morning in development of its latest diabetes product Degludec. The FDA decided … Continue Reading
Read now